Treating Parents to Reduce NICU Transmission of Staphylococcus aureus (TREAT PARENTS) trial: protocol of a multisite randomised, double-blind, placebo-controlled trial

Aaron M Milstone, Danielle W Koontz, Annie Voskertchian, Victor O Popoola, Kathleen Harrelson, Tracy Ross, Susan W Aucott, Maureen M Gilmore, Karen C Carroll, Elizabeth Colantuoni, Aaron M Milstone, Danielle W Koontz, Annie Voskertchian, Victor O Popoola, Kathleen Harrelson, Tracy Ross, Susan W Aucott, Maureen M Gilmore, Karen C Carroll, Elizabeth Colantuoni

Abstract

Introduction: More than 33,000 healthcare-associated infections occur in neonatal intensive care units (NICUs) each year in the USA. Parents, rather than healthcare workers, may be a reservoir from which neonates acquire Staphylococcus aureus (S. aureus) colonisation in the NICU. This study looks to measure the effect of treating parents with short course intranasal mupirocin and topical chlorhexidine antisepsis on acquisition of S. aureus colonisation and infection in neonates.

Methods and analysis: The TREAT PARENTS trial (Treating Parents to Reduce Neonatal Transmission of S. aureus) is a multicentre randomised, masked, placebo-controlled trial. Shortly after a neonate is admitted to the NICU, parents will be tested for S. aureus colonisation. If either parent screens positive for S. aureus, then both parents as a pair will be enrolled and randomised to one of the two possible masked treatment arms. Arm 1 will include assignment to intranasal 2% mupirocin plus topical antisepsis with chlorhexidine gluconate impregnated cloths for 5 days. Arm 2 will include assignment to placebo ointment and placebo cloths for skin antisepsis for 5 days. The primary outcome will be neonatal acquisition of an S. aureus strain that is concordant to the parental baseline S. aureus strain as determined by periodic surveillance cultures or a culture collected during routine clinical care that grows S. aureus. Secondary outcomes will include neonatal acquisition of S. aureus, neonatal S. aureus infection, eradication of S. aureus colonisation in parents, natural history of S. aureus colonisation in parents receiving placebo, adverse reactions to treatment, feasibility of intervention, and attitudes and behaviour in consented parents. Four hundred neonate-parent pairs will be enrolled.

Ethics and dissemination: The study was approved by Johns Hopkins University IRB in June 2014 (IRB number 00092982). Protocol V.7 was approved in November 2014. Findings will be published in peer-reviewed journals.

Trial registration number: NCT02223520.

Keywords: MICROBIOLOGY; NEONATOLOGY.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Figure 1
Figure 1
Overview of study design (NICU, neonatal intensive care unit).

References

    1. Klevens RM, Edwards JR, Richards CL Jr et al. . Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160–6.
    1. Scott RD. The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention. Secondary The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention 2009.
    1. Schlapbach LJ, Aebischer M, Adams M et al. . Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 2011;128:e348–e57. 10.1542/peds.2010-3338
    1. Stoll BJ, Hansen NI, Adams-Chapman I et al. . Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357–65. 10.1001/jama.292.19.2357
    1. Hocevar SN, Edwards JR, Horan TC et al. . Device-associated infections among neonatal intensive care unit patients: incidence and associated pathogens reported to the National Healthcare Safety Network, 2006–2008. Infect Control Hosp Epidemiol 2012;33:1200–6. 10.1086/668425
    1. Shane AL, Hansen NI, Stoll BJ et al. . Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics 2012;129:e914–22. 10.1542/peds.2011-0966
    1. Ericson J, Popoola VO, Smith PB et al. . Burden of invasive Staphylococcus aureus infections in hospitalized infants. JAMA Pediatr (in press).
    1. Milstone AM, Budd A, Shepard JW et al. . Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study. Infect Control Hosp Epidemiol 2010;31:558–60. 10.1086/652449
    1. Jimenez-Truque N, Tedeschi S, Saye EJ et al. . Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 2012;129:e1252–9. 10.1542/peds.2011-2308
    1. Leshem E, Maayan-Metzger A, Rahav G et al. . Transmission of Staphylococcus aureus from mothers to newborns. Pediatr Infect Dis J 2012;31:360–3. 10.1097/INF.0b013e318244020e
    1. Mitsuda T, Arai K, Fujita S et al. . Demonstration of mother-to-infant transmission of Staphylococcus aureus by pulsed-field gel electrophoresis. Eur J Pediatr 1996;155:194–9. 10.1007/BF01953937
    1. Sax H, Posfay-Barbe K, Harbarth S et al. . Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect 2006;63:93–100. 10.1016/j.jhin.2005.11.016
    1. Al-Tawfiq JA. Father-to-infant transmission of community-acquired methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2006;27:636–7. 10.1086/505097
    1. Barbe C, Santerne B, Lemartelleur L et al. . Prevalence of meticillin-resistant Staphylococcus aureus in expressed breast milk in a neonatal intensive care unit. J Hosp Infect 2008;69: 195–7. 10.1016/j.jhin.2008.02.013
    1. Behari P, Englund J, Alcasid G et al. . Transmission of methicillin-resistant Staphylococcus aureus to preterm infants through breast milk. Infect Control Hosp Epidemiol 2004;25: 778–80. 10.1086/502476
    1. Gastelum DT, Dassey D, Mascola L et al. . Transmission of community-associated methicillin-resistant Staphylococcus aureus from breast milk in the neonatal intensive care unit. Pediatr Infect Dis J 2005;24:1122–4. 10.1097/01.inf.0000189983.71585.30
    1. Pinter DM, Mandel J, Hulten KG et al. . Maternal-infant perinatal transmission of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Am J Perinatol 2009;26:145–51. 10.1055/s-0028-1095179
    1. Morel AS, Wu F, Della-Latta P et al. . Nosocomial transmission of methicillin-resistant Staphylococcus aureus from a mother to her preterm quadruplet infants. Am J Infect Control 2002;30:170–3. 10.1067/mic.2002.119819
    1. Conceicao T, Aires de Sousa M, Miragaia M et al. . Staphylococcus aureus reservoirs and transmission routes in a Portuguese Neonatal Intensive Care Unit: a 30-month surveillance study. Microb Drug Resist 2012;18:116–24. 10.1089/mdr.2011.0182
    1. Popoola VO, Budd A, Wittig SM et al. . Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol 2014;35:412–18. 10.1086/675594
    1. Popoola VO, Milstone AM. Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit. J Perinatol 2014;34:805–10. 10.1038/jp.2014.128
    1. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002;359:1686–9. 10.1016/S0140-6736(02)08594-X
    1. Tsiatis AA, Davidian M, Zhang M et al. . Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: a principled yet flexible approach. Stat Med 2008;27:4658–77. 10.1002/sim.3113
    1. Colantuoni E, Rosenblum M. Leveraging prognostic baseline variables to gain precision in randomized trials. Stat Med 2015;34:2602–17. 10.1002/sim.6507
    1. Rotnitzky A, Lei Q, Sued M et al. . Improved double-robust estimation in missing data and causal inference models. Biometrika 2012;99:439–56. 10.1093/biomet/ass013

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe